In a hepatocellular carcinoma (HCC) bearing mouse model, RT alone increased the expression of VEGF (38.7 ± 5.8), while combination therapy with RE reduced VEGF (15.0 ± 1.8) expression as well as the MVD [142]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.